Evidence map›Paper›PMID 29985329›Full record

ArticleJournal of visualized experiments : JoVE2018

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder.

Andrea L Dimet, Irma E Cisneros, Robert G Fox, Sonja J Stutz, Noelle C Anastasio, Kathryn A Cunningham, Kelly T Dineley

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  5. Acute Negative Allosteric Modulation of MACS chemical neuroscience · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andrea L DimetCenter for Addiction Research, University of Texas Medical Branch; Institute for Translational Sciences, University of Texas Medical Branch; Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch.
Irma E CisnerosCenter for Addiction Research, University of Texas Medical Branch; Department of Neurology, University of Texas Medical Branch; Department of Pathology, University of Texas Medical Branch.
Robert G FoxCenter for Addiction Research, University of Texas Medical Branch; Department of Pharmacology and Toxicology, University of Texas Medical Branch.
Sonja J StutzCenter for Addiction Research, University of Texas Medical Branch; Department of Pharmacology and Toxicology, University of Texas Medical Branch.
Noelle C AnastasioCenter for Addiction Research, University of Texas Medical Branch; Department of Pharmacology and Toxicology, University of Texas Medical Branch.
Kathryn A CunninghamCenter for Addiction Research, University of Texas Medical Branch; Department of Pharmacology and Toxicology, University of Texas Medical Branch.
Kelly T DineleyCenter for Addiction Research, University of Texas Medical Branch; Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch; Department of Neurology, University of Texas Medical Branch; ktdinele@utmb.edu.
The University of Texas Medical Branch at Galveston · USInstitute for Neurodegenerative Disorders · US

Funding

UTMB Clinical and Translational Science AwardUL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI URBAN, RANDALL J · 2015 to 2024
$40.0M
Molecular Mechanisms of Environmental InjuryT32ES007254 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI AMEREDES, BILL T · 1990 to 2022
$6.6M
Translational Explorations in Substance Use DisordersT32DA007287 · NIDA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Kathryn A. Cunningham, Jonathan Dean Hommel · 1994 to 2026
$4.7M
NCATS NIH HHS UL1 TR001439NIDA NIH HHS T32 DA007287NIEHS NIH HHS T32 ES007254
6 · The paper itself

Abstract

Cocaine use disorder (CUD) follows a trajectory of repetitive self-administration during which previously neutral stimuli gain incentive value. Cue reactivity, the sensitivity to cues previously linked with the drug-taking experience, plays a prominent role in human craving during abstinence. Cue reactivity can be assessed as the attentional orientation toward drug-associated cues that is measurable as appetitive approach behavior in both preclinical and human studies. Herein describes an assessment of cue reactivity in rats trained to self-administer cocaine. Cocaine self-administration is paired with the presentation of discrete cues that act as conditioned reinforcers (i.e., house light, stimulus light, infusion pump sounds). Following a period of abstinence, lever presses in the cocaine self-administration context accompanied by the discrete cues previously paired with cocaine infusion are measured as cue reactivity. This model is useful to explore neurobiological mechanisms underlying cue reactivity processes as well as to assess pharmacotherapies to suppress cue reactivity and therefore, modify relapse vulnerability. Advantages of the model include its translational relevance, and its face and predictive validities. The primary limitation of the model is that the cue reactivity task can only be performed infrequently and must only be used in short duration (e.g., 1 hour), otherwise rats will begin to extinguish the pairing of the discrete cues with the cocaine stimulus. The model is extendable to any positively reinforcing stimulus paired with discrete cues; though particularly applicable to drugs of abuse, this model may hold future applications in fields such as obesity, where palatable food rewards can act as positively reinforcing stimuli.

Indexed as

CuesAnimalsCocaine-Related DisordersConditioning, OperantMaleRatsRats, Sprague-Dawley

Identifiers

PMID29985329
PMCPMC6101759
OpenAlexW2809166339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.